61 Can the Use of Tumor Margin Markers for Intraoperative Specimen Radiographs Decrease the Rate of Margin Positivity During Breast Conservation Therapy?

Publication
Article
Miami Breast Cancer Conference® Abstracts Supplement42nd Annual Miami Breast Cancer Conference® - Abstracts
Volume 39
Issue 4

61 Can the Use of Tumor Margin Markers for Intraoperative Specimen Radiographs Decrease the Rate of Margin Positivity During Breast Conservation Therapy?

61 Can the Use of Tumor Margin Markers for Intraoperative Specimen Radiographs Decrease the Rate of Margin Positivity During Breast Conservation Therapy?

Background/Significance

The margin status after a lumpectomy is critical to determine the risk of local recurrence. Current guidelines recommend “no ink on tumor” as adequate negative margins for invasive carcinoma. Several studies report that up to 40% of patients may have positive margins requiring a second operation for excision. As such, controversy exists regarding the intraoperative management of margins, with some groups supporting routine cavity shave margins and others favoring selective margin excision based on examination of the specimen plus interpretation of intraoperative radiographs. We hypothesized that a commercially available tumor marking system used at the time of specimen radiography would help reduce the rate of margin positivity.

Materials and Methods

After Institutional Review Board approval, a retrospective review of a prospectively collected cohort of patients was conducted. We included patients older than 18 years diagnosed with invasive breast cancer undergoing breast conservation therapy. At the completion of the lumpectomy, the specimen margins were labeled using clips from the selected commercial tumor marking system; this was followed by a 2-view radiography to determine if shave margins needed to be obtained. The distance between the margin and the tumor border was recorded using a standard millimeter ruler. The radiograph was interpreted by the lead surgeon and shave margins (selective vs complete) were excised at the discretion of the lead surgeon as well. A control group with similar patient characteristics was composed using the same inclusion criteria. In this group, the commercial tumor marking system was not utilized, and the management of the margins was determined by the lead surgeon. Continuous variables are presented as mean with standard deviation and compared using t-test. Categorical variables are presented as frequencies and percentages and compared using χ2tests or Fisherexact tests, as applicable (Table). Significance level was set at 0.05. Analyses were performed using SAS software (Version 9.4).

Results

One hundred and five patients in the study group were compared with 92 patients in the control group. The mean age in both groups was 63 and 64 years, respectively. In the study group, 39% of the cohort underwent selective shave margin excision, and 7% underwent complete margin excision based on the use of the tumor marking system. The control group had a 42% rate of selective margin excision and a significantly higher rate of complete margin excision of 20%. No margins were excised in 53% of the study group vs 37% on the control group. Final pathology of the study and control groups demonstrated positive margins in 23% and 20%, respectively, with no significant difference between the groups.

Conclusion

The use of the tumor marking system did contribute to decreasing the number of patients requiring either selective or complete margin excision; however, no significant difference was found between the groups regarding the rate of margin positivity among the patients who underwent margin excision with and without the use of the tumor marking system.

Articles in this issue

61 Can the Use of Tumor Margin Markers for Intraoperative Specimen Radiographs Decrease the Rate of Margin Positivity During Breast Conservation Therapy?
61 Can the Use of Tumor Margin Markers for Intraoperative Specimen Radiographs Decrease the Rate of Margin Positivity During Breast Conservation Therapy?
63 Intraoperative Radiation and External Beam Radiation After Breast-Conserving Surgery in an Ethnic Minority Population: Patient Reported Outcomes Using BREAST-Q
63 Intraoperative Radiation and External Beam Radiation After Breast-Conserving Surgery in an Ethnic Minority Population: Patient Reported Outcomes Using BREAST-Q
64 A Prospective Study to Accurately Define the Nipple-Ward Margins in Patients Undergoing Lumpectomy for Breast Cancer
64 A Prospective Study to Accurately Define the Nipple-Ward Margins in Patients Undergoing Lumpectomy for Breast Cancer
65 The Outcomes of Nipple Sparing Goldilocks Mastectomy in a Primarily Overweight and Obese Population
65 The Outcomes of Nipple Sparing Goldilocks Mastectomy in a Primarily Overweight and Obese Population
67 Confocal Laser Scanning Microscopy (CLSM) for Intraoperative Histopathological Margin Assessment in Breast Conservation Surgery
67 Confocal Laser Scanning Microscopy (CLSM) for Intraoperative Histopathological Margin Assessment in Breast Conservation Surgery
68 Upper Extremity Disability Assessment Following Breast Cancer Surgery Using QuickDASH in an Ethnic Minority Population
68 Upper Extremity Disability Assessment Following Breast Cancer Surgery Using QuickDASH in an Ethnic Minority Population
70 Malignancy Upgrade Rates of Discordant Breast Lesions
70 Malignancy Upgrade Rates of Discordant Breast Lesions
71 Beyond the Surface: Suspicious Nipple Lesions
71 Beyond the Surface: Suspicious Nipple Lesions
72 Breast Cancer After Breast Augmentation: A Multicenter Collaborative Study Of Patient Management and Outcomes
72 Breast Cancer After Breast Augmentation: A Multicenter Collaborative Study Of Patient Management and Outcomes
73 Short- and Long-Term Outcomes in Use of Titanium-Coated Polypropylene Meshes in Immediate Breast Reconstruction: A Cost-Effective and Safe Option?
73 Short- and Long-Term Outcomes in Use of Titanium-Coated Polypropylene Meshes in Immediate Breast Reconstruction: A Cost-Effective and Safe Option?
74 Lessons Learned From a Breast Surgery ERAS Program in an Oncologic Ambulatory Center
74 Lessons Learned From a Breast Surgery ERAS Program in an Oncologic Ambulatory Center
75 Comparing 21-Gene Assay Recurrence Scores Before and After Preoperative Radiation Boost in Patients Enrolled in a Phase 2 Prospective Clinical Trial
75 Comparing 21-Gene Assay Recurrence Scores Before and After Preoperative Radiation Boost in Patients Enrolled in a Phase 2 Prospective Clinical Trial
76 Electromagnetic Chip Bracketed vs Wire Bracketed Localization in Breast Conserving Surgery
76 Electromagnetic Chip Bracketed vs Wire Bracketed Localization in Breast Conserving Surgery
77 A Radio Opaque Suture May Improve Radiation Target Delineation in Post Lumpectomy Patients With Breast Cancer: A Retrospective Analysis
77 A Radio Opaque Suture May Improve Radiation Target Delineation in Post Lumpectomy Patients With Breast Cancer: A Retrospective Analysis
78 Comparison of Positive Margin Rate of Breast Cancer in Higher BMI Patients
78 Comparison of Positive Margin Rate of Breast Cancer in Higher BMI Patients

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Multidisciplinary care can help ensure that treatment planning does not deviate from established guidelines for inflammatory breast cancer management.
A study aimed to determine the variables that correlated with extravasation rates in patients receiving radiation injection therapy.
Extravasation with beta emitters may elicit more drastic adverse effects due to their higher radiation dose.
Photographic and written documentation can help providers recognize inflammatory breast cancer symptoms across diverse populations.
The use of guideline-concordant care in breast cancer appears to be more common in White populations than Black populations.
Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Testing a patient’s genetics may influence decisions such as using longer courses of radiotherapy, says Rachit Kumar, MD.
Multidisciplinary collaboration may help in minimizing the treatment burden among patients with prostate cancer, according to Curtiland Deville Jr., MD.
Related Content